Treatment of Severe IgA Nephropathy Patients with Liver and Kidney Yin Deficiency Syndrome by Traditional Chinese Medicine Syndrome Differentiation Combinated with Losartan Potassium: A Prospective and Multicentered Clinical Study

WANG Jie; ZHANG Xinxian; CHEN Xiaonong; LU Jianrao; WANG Zhaohui; HU Jing; GAO Yachan; XU Hong; SHEN Qian; JIANG Gengru; GU Yingli; HE Liqun

doi:10.13288/j.11-2166/r.2019.22.010

您当前的位置：

首页 >

文章列表页 >

Treatment of Severe IgA Nephropathy Patients with Liver and Kidney Yin Deficiency Syndrome by Traditional Chinese Medicine Syndrome Differentiation Combinated with Losartan Potassium: A Prospective and Multicentered Clinical Study

更新时间：2021-11-10

- Treatment of Severe IgA Nephropathy Patients with Liver and Kidney Yin Deficiency Syndrome by Traditional Chinese Medicine Syndrome Differentiation Combinated with Losartan Potassium: A Prospective and Multicentered Clinical Study
- Journal of Traditional Chinese Medicine Vol. 60, Issue 22, Pages: 1929-1934(2019)
- 作者机构：
  
  1. 上海中医药大学附属曙光医院
  2. 上海交通大学附属瑞金医院
  3. 上海中医药大学附属第七人民医院
  4. 复旦大学附属儿科医院
  5. 上海交通大学附属新华医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2019.22.010
  CLC： R692.31
- Published：2019
- 稿件说明：
移动端阅览
[1]王杰,张昕贤,陈晓农,路建饶,王朝晖,胡静,高雅婵,徐虹,沈茜,蒋更如,顾颖莉,何立群.中医辨证联合氯沙坦钾治疗肝肾阴虚型重症IgA肾病的前瞻性多中心临床研究[J].中医杂志,2019,60(22):1929-1934.

WANG Jie, ZHANG Xinxian, CHEN Xiaonong, et al. Treatment of Severe IgA Nephropathy Patients with Liver and Kidney Yin Deficiency Syndrome by Traditional Chinese Medicine Syndrome Differentiation Combinated with Losartan Potassium: A Prospective and Multicentered Clinical Study[J]. Journal of Traditional Chinese Medicine2019, 60(22): 1929-1934.
[1]王杰,张昕贤,陈晓农,路建饶,王朝晖,胡静,高雅婵,徐虹,沈茜,蒋更如,顾颖莉,何立群.中医辨证联合氯沙坦钾治疗肝肾阴虚型重症IgA肾病的前瞻性多中心临床研究[J].中医杂志,2019,60(22):1929-1934. DOI： 10.13288/j.11-2166/r.2019.22.010.

WANG Jie, ZHANG Xinxian, CHEN Xiaonong, et al. Treatment of Severe IgA Nephropathy Patients with Liver and Kidney Yin Deficiency Syndrome by Traditional Chinese Medicine Syndrome Differentiation Combinated with Losartan Potassium: A Prospective and Multicentered Clinical Study[J]. Journal of Traditional Chinese Medicine2019, 60(22): 1929-1934. DOI： 10.13288/j.11-2166/r.2019.22.010.

摘要

目的观察中医辨证联合氯沙坦钾对肝肾阴虚型重症IgA肾病的临床疗效及安全性。方法采用前瞻性多中心随机对照方法

于2016年9月至2018年8月5个中心共纳入156例患者

随机分为治疗组（补益肝肾颗粒剂和氯沙坦钾片治疗）和对照组（补益肝肾颗粒剂模拟剂和氯沙坦钾片治疗）各78例。每8周测定患者24小时尿蛋白定量（24hUpro）、尿微量白蛋白/肌酐（MA/Cr）、血肌酐（SCr）、血尿素氮（BUN）、血白蛋白（Alb）、肾小球滤过率（e GFR）、血红蛋白（Hb）

同时进行中医证候评分

共观察24周

评价中医证候疗效及临床疗效。结果治疗组临床疗效总有效率为70. 67%

高于对照组的38. 57%（P <0. 01）。治疗组中医证候疗效总有效率88. 00%

高于对照组的45. 72%（P <0. 01）。与治疗前比较

治疗组治疗8、16、24周24hUPro、MA/Cr、SCr、BUN明显下降

eGFR明显升高（P <0. 05或P <0. 01）;对照组治疗24周24hUPro、SCr、BUN均下降（P <0. 05）

且治疗组治疗24周24hUPro、MA/Cr、SCr、BUN明显低于对照组

eGFR明显高于对照组（P <0. 05）。结论中医辨证联合氯沙坦钾能够有效降低肝肾阴虚型重症IgA肾病患者24hUPro、MA/Cr、BUN、SCr水平

提高患者eGFR

改善患者的肾功能

延缓IgA肾病的进展。

Abstract

Objective To evaluate the efficacy and safety of syndrome differentiation-based treatment with traditional Chinese medicine（TCM） and losartan potassium in treating severe IgA nephropathy with liver and kidney yin deficiency syndrome. Methods A prospective multicentered randomize-controlled trial was conducted. A total of156 patients from 5 centers were enrolled from September 2016 to August 2018. They were randomly divided into a treatment group treated with Buyi Ganshen Granules（补益肝肾颗粒） and Losartan Potassium Tablets and a control group treated with Buyi Ganshen Granules simulant and Losartan Potassium Tablets)

with 78 cases in each group.24-hour urinary protein quantity（24 hUpro）

urinary microalbumin/creatinine（MA/Cr）

serum creatinine（SCr）

blood urea nitrogen（BUN）

serum albumin（Alb） and glomerular filtration rate（eGFR）

Hemoglobin（Hb） were detected every 8 weeks. Traditional Chinese medicine（TCM） syndrome scores were determined

for a total of 24 weeks. The efficacy of TCM syndromes and clinical efficacy were evaluated. Results The total effective rate of the treatment group was 70. 67%

which was higher than 38. 57% of the control group（P < 0. 01）. The total effective rate of TCM syndromes in the treatment group was 88. 00%

which was higher than 45. 72% in the control group（P < 0. 01）. Compared with before treatment

24 hUPro

MA/Cr

SCr and BUN were significantly decreased and eGFR was significantly increased in the treatment group at 8

16 and 24 weeks（P < 0. 05 or P < 0. 01）. The control group had a decrease in 24 hUPro

SCr and BUN at 24 weeks of treatment（P < 0. 05）. 24 hUPro

MA/Cr

SCr

BUN in the treatment group was significantly lower than those of the control group at 24 weeks of treatment

and eGFR was significantly higher than that of the control group（P < 0. 05）. Conclusion Combination of TCM syndrome differentiation and losartan potassium could effectively reduce 24 hUPro

MA/Cr

BUN

SCr levels

increase eGFR in patients with severe IgA nephropathy of liver and kidney yin deficiency syndrome

and could improve renal function and delay the progression of IgA nephropathy.

关键词

Keywords

references

查看原文

Views

221

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Bushen Runzao Fang（补肾润燥方） on Exocrine Gland Function and Sex Hormone of Middle-aged and Elderly Female Patients with Sjogren’s Syndrome in Liver and Kidney Yin Deficiency Type

Construction and Application of "Source-Pivot-Convergence" Pattern Identification and Treatment Model for Malignant Tumors

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

LI Guolie's Experience in Treating Orthostatic Hypotension from the Perspective of "Raising the Clear and Directing the Turbid Downward"

Research on the Correlation Between "Tiangui （天癸）" and Female Reproductive Genetic Diseases

Related Author

ZHENG Yueqi

YANG Guanghui

HE Yikun

PAN Xin

XU Xiaofang

WU Huihui

CHEN Meng

ZHANG Kai

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰